scispace - formally typeset
Search or ask a question
Institution

University of Medicine and Dentistry of New Jersey

Education
About: University of Medicine and Dentistry of New Jersey is a based out in . It is known for research contribution in the topics: Population & Pregnancy. The organization has 14634 authors who have published 19610 publications receiving 1041794 citations.
Topics: Population, Pregnancy, Poison control, Gene, Receptor


Papers
More filters
Journal ArticleDOI
TL;DR: Female athletes appear to have a differing response of the proximal hip musculature to LE injury or LBP, as compared with their male counterparts, as it may be important in the prevention of LE injury and LBP in collegiate athletes.
Abstract: Objective To determine the relationship of previous lower extremity (LE) injury and/or low back pain (LBP) on hip abduction and extension strength. Design Cohort study of college athletes at time of preparticipation screening physical. Setting An NCAA Division I college. Participants Two hundred ten college athletes (140 males and 70 females) from an NCAA Division I school. Main outcome measures Mean and maximal hip abduction and extension strengths were recorded using a specially designed dynamometer anchoring station. Previous injury to the LE or LBP in the past year was recorded via personal interview at the time of screening and verified by review of previous injury records. Results A significant difference in side-to-side symmetry of maximum hip extension strength was observed in female subjects who reported LE injury or LBP as compared to those who did not. Side-to-side difference in hip strength, however, did not differ between male athletes, regardless of reported LE injury or LBP status. Conclusion Female athletes appear to have a differing response of the proximal hip musculature to LE injury or LBP, as compared with their male counterparts. Research is under way to further validate these findings. Clinical relevance This study provides some reasoning to support the screening of hip strength during the preparticipation physical, as it may be important in the prevention of LE injury and LBP in collegiate athletes.

299 citations

Journal ArticleDOI
TL;DR: Dose-dependent associations with both the rate and extent of clinical response were observed across the four dose groups, and significant and sustained concentration-dependent improvements in psoriatic lesions were observed in most subjects.

299 citations

Journal ArticleDOI
TL;DR: Treatment of HL-60 cells with increasing concentrations of ONOO confirms the concentration dependence of apoptosis as evidenced by degradation of nuclear DNA of these cells into integer multiples of approximately 200 base pairs and evidence of condensation of chromatin and nuclear fragmentation shown by propidium iodide staining.

299 citations

Journal Article
TL;DR: Inhibition of P-gp expression by small interfering RNA enhanced the intracellular accumulation of and selectively restored sensitivity to drugs transported by P- gp, indicating that RNA interference can modulate MDR in preclinical models.
Abstract: Overexpression of P-glycoprotein (P-gp), the MDR1 gene product, confers multidrug resistance (MDR) to cancer cells. Clinically, MDR is one of the major causes for chemotherapeutic treatment failure in cancer patients. To explore a new approach to circumventing MDR, we adopted RNA interference to target MDR1 gene expression. RNA interference is a conserved biological response to double-stranded RNA, which results in sequence-specific gene silencing [G. J. Hannon, Nature (Lond.), 418: 244-251, 2002]. We report that introduction of an MDR1-targeted small interfering RNA duplex into drug-resistant cancer cells markedly inhibited the expression of MDR1 mRNA and P-gp, as determined by reverse transcription-PCR and Western blot. Inhibition of P-gp expression by small interfering RNA enhanced the intracellular accumulation of and selectively restored sensitivity to drugs transported by P-gp. These studies indicate that RNA interference can modulate MDR in preclinical models.

299 citations

Journal ArticleDOI
TL;DR: There are systematic differences in poly(A) site usage among human tissues, and both trans-acting factors and cis-regulatory elements may be involved in regulating alternative polyadenylation in different tissues.
Abstract: Background Alternative polyadenylation is one of the mechanisms in human cells that give rise to a variety of transcripts from a single gene. More than half of the human genes have multiple polyadenylation sites (poly(A) sites), leading to variable mRNA and protein products. Previous studies of individual genes have indicated that alternative polyadenylation could occur in a tissue-specific manner.

298 citations


Authors

Showing all 14639 results

NameH-indexPapersCitations
John Q. Trojanowski2261467213948
Virginia M.-Y. Lee194993148820
Danny Reinberg14534268201
Michael F. Holick145767107937
Tasuku Honjo14171288428
Arnold J. Levine139485116005
Aaron T. Beck139536170816
Charles J. Yeo13667276424
Jerry W. Shay13363974774
Chung S. Yang12856056265
Paul G. Falkowski12737864898
Csaba Szabó12395861791
William C. Roberts122111755285
Bryan R. Cullen12137150901
John R. Perfect11957352325
Network Information
Related Institutions (5)
University of California, San Francisco
186.2K papers, 12M citations

97% related

University of Alabama at Birmingham
86.7K papers, 3.9M citations

96% related

Johns Hopkins University School of Medicine
79.2K papers, 4.7M citations

96% related

University of Texas Southwestern Medical Center
75.2K papers, 4.4M citations

96% related

National Institutes of Health
297.8K papers, 21.3M citations

96% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20226
202113
20208
201917
201823
201736